(Q44882258)
Statements
1 reference
Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatil (English)
1 reference
J D Veldhuis
1 reference
M Bidlingmaier
1 reference
S M Anderson
1 reference
Z Wu
1 reference
C J Strasburger
1 reference
1 July 2001
1 reference
1 reference
86
1 reference
7
1 reference
3304-3310
1 reference
Identifiers
1 reference
1 reference